IRIS
DEROSA, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.140
AS - Asia 18.776
EU - Europa 14.276
SA - Sud America 2.468
Continente sconosciuto - Info sul continente non disponibili 611
AF - Africa 565
OC - Oceania 36
Totale 61.872
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.565
CN - Cina 10.093
SG - Singapore 3.999
IE - Irlanda 2.943
UA - Ucraina 2.537
DE - Germania 2.071
BR - Brasile 1.824
FI - Finlandia 1.686
HK - Hong Kong 1.683
VN - Vietnam 1.355
RU - Federazione Russa 1.226
IT - Italia 1.199
FR - Francia 818
SE - Svezia 804
GB - Regno Unito 496
IN - India 353
CA - Canada 307
ZA - Sudafrica 268
BD - Bangladesh 263
AR - Argentina 205
IQ - Iraq 154
MX - Messico 131
NL - Olanda 112
EC - Ecuador 110
TR - Turchia 103
JP - Giappone 99
ID - Indonesia 88
PK - Pakistan 81
CO - Colombia 80
VE - Venezuela 70
MA - Marocco 64
ES - Italia 61
UZ - Uzbekistan 56
PH - Filippine 55
PL - Polonia 51
CL - Cile 49
SA - Arabia Saudita 48
EG - Egitto 47
MY - Malesia 45
TN - Tunisia 43
PE - Perù 41
KE - Kenya 40
JO - Giordania 38
PY - Paraguay 36
BE - Belgio 32
IR - Iran 32
BO - Bolivia 27
RO - Romania 27
CR - Costa Rica 25
LT - Lituania 23
IL - Israele 22
TH - Thailandia 22
AL - Albania 21
GR - Grecia 21
JM - Giamaica 21
AE - Emirati Arabi Uniti 20
KZ - Kazakistan 20
AZ - Azerbaigian 19
CH - Svizzera 19
NP - Nepal 19
UY - Uruguay 19
AT - Austria 18
DZ - Algeria 18
ET - Etiopia 18
MU - Mauritius 18
NZ - Nuova Zelanda 16
PA - Panama 16
AU - Australia 15
DO - Repubblica Dominicana 15
EU - Europa 15
CZ - Repubblica Ceca 14
KG - Kirghizistan 14
NI - Nicaragua 14
TT - Trinidad e Tobago 13
BH - Bahrain 12
PT - Portogallo 12
HN - Honduras 11
HU - Ungheria 11
MK - Macedonia 11
SN - Senegal 11
KR - Corea 9
OM - Oman 9
QA - Qatar 9
RS - Serbia 9
KW - Kuwait 8
MD - Moldavia 8
AM - Armenia 7
BG - Bulgaria 6
CI - Costa d'Avorio 6
GE - Georgia 6
LV - Lettonia 6
DK - Danimarca 5
LB - Libano 5
LK - Sri Lanka 5
XK - ???statistics.table.value.countryCode.XK??? 5
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
EE - Estonia 4
GT - Guatemala 4
LA - Repubblica Popolare Democratica del Laos 4
Totale 61.181
Salva come PNG Salva come JPEG
Città #
Jacksonville 3.398
Dublin 2.943
Chandler 2.846
San Jose 2.520
Nanjing 2.513
Singapore 1.871
Ashburn 1.805
Hong Kong 1.636
Dallas 1.614
Boardman 1.103
Nanchang 1.092
Beijing 971
Princeton 809
Council Bluffs 806
Shenyang 768
Hebei 702
Lawrence 700
Changsha 685
Wilmington 656
Lauterbourg 633
Jiaxing 575
Munich 537
Medford 521
Los Angeles 488
Ho Chi Minh City 465
Hangzhou 433
Tianjin 426
Helsinki 419
Hanoi 340
Redondo Beach 302
Buffalo 273
New York 245
Johannesburg 229
Milan 210
Moscow 203
Santa Clara 196
São Paulo 181
Toronto 152
Shanghai 149
Ann Arbor 138
Seattle 125
Woodbridge 115
Norwalk 112
Tokyo 90
Orem 88
Fairfield 78
Jinan 77
Turku 77
San Francisco 71
Baghdad 70
Frankfurt am Main 69
Kunming 69
Des Moines 68
Atlanta 66
Montreal 66
Brooklyn 65
Da Nang 63
Guangzhou 60
Chennai 58
Rio de Janeiro 58
Cambridge 56
Chicago 54
Quito 54
Ningbo 52
Haiphong 51
Pavia 51
Dhaka 50
Rome 49
Tashkent 49
London 47
Phoenix 46
Zhengzhou 46
Verona 43
Pune 37
Warsaw 37
Stockholm 36
Denver 35
Nairobi 33
Belo Horizonte 32
Guayaquil 32
Amman 31
Boston 31
Campinas 30
Houston 30
Orange 30
Biên Hòa 29
Brussels 29
Columbus 29
Mexico City 29
Mumbai 29
Lahore 27
Brasília 26
Hải Dương 26
Charlotte 25
New Delhi 25
Poplar 25
The Dalles 25
Washington 25
Curitiba 24
Eindhoven 24
Totale 39.537
Salva come PNG Salva come JPEG
Nome #
Effetto del lactobacillus paracasei I1688 e del lactobacillus salivarius I1794 (psmix®) sui lipidi ematici nell’ipercolesterolemia lieve 367
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 349
Safety and efficacy of alpha lipoic acid during 4 years of observation: A retrospective, clinical trial in healthy subjects in primary prevention 314
Effects of oral administration of alprazolam and lorazepam as hypnotics on cardiovascular parameters in hypertensive patients. 312
Evaluation of the Effect on Sexual Performance of a Nutraceutical Combination Containing Alpha Lipoic Acid, Vitis vinifera L. and Ginkgo biloba, Compared to Placebo, Avanafil or a Combination of Nutraceutical Plus Avanafil in Males With Type 2 Diabetes Mellitus With Erectile Dysfunction 309
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 305
Anemia in patients with Covid-19: pathogenesis and clinical significance 290
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 253
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial 245
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients 237
A randomized, placebo-controlled study about the effect of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters 205
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial 189
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 178
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 164
A possible way to improve the glycemic control and the beta cell function during three years: the triple therapy. 159
A multicenter, randomised, single-blind study on the effects of exenatide or glimepiride on insulin resistance. 155
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 153
An evaluation of a nutraceutical with berberine, curcumin, inositol, banaba and chromium picolinate in patients with fasting dysglycemia 147
A comparison between sitagliptin or glibenclamide in addition to metformin+pioglitazone on glycemic control and beta-cell function: the triple oral therapy 145
Abscisic Acid Treatment in Patients with Prediabetes. 144
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 141
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia 140
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome 138
Probiotic Therapy With VSL#3® in Patients With NAFLD: A Randomized Clinical Trial 135
A nutraceutical based approach to reduce cholesterolaemia in patients previously intolerant of more than a statin: a pilot study 135
Confronto tra nateglinide più metformina rispetto a glibenclamide più metformina sul metabolismo glucidico nei pazienti diabetici di tipo 2: studio ad 1 anno 134
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 133
Different actions of losartan and ramipril on adipose tissue Activity and vascular remodeling biomarkers in hypertensive patients 133
Adipocytokines levels in obese and non-obese subjects, an observational study 133
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients 132
A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus 132
Association between low-molecular weight apolipoprotein(a) isoforms and obesity in Italian women 131
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 131
A comparison study of Lp(a) plasma levels distribution between normo and hypertensive subjects with high BMI 131
A systematic reviewandmeta-analysis of randomized controlled trials investigating the effects of supplementationwith Nigella sativa (black seed) on blood pressure 131
Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study 130
Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients 129
Diagnostico y Tratamiento de los desordenes lipidicos. Mc Graw Hill Education 2014. 129
Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial 128
A randomized, double blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetic patients already treated with pioglitazone and metformin: a three years study 128
Confronto tra pioglitazone e rosiglitazone sul metabolismo glucidico e lipidico nei soggetti diabetici di tipo 2 in terapia con metformina 127
A randomized, double blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function. 127
Atorvastatin-amlodipine combination and fibrinolytic balance in hypertensive hypercholesterolemic insulin-resistent patients 127
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load 127
Comparison between diet, orlistat and fluvastatin in obese patients with mild hypertension and hypercholesterolemia 126
Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients 126
Effect of valsartan or olmesartan addition to amlodipine/hydrochlorotiazide combination on 24 hour blood pressure reduction in essential hypertension 125
Effetti metabolici di telmisartan e irbesartan nei pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 125
Diarrea in paziente diabetico 125
Actions of glimepiride plus metformin compared to rosiglitazone plus metformin on glucose metabolism, fibrinolytic, and coagulation measurements in Type 2 diabetic patients. 125
Differential effect of candesartan and olmesartan on adipose tissue activity biomarkers in type 2 diabetic hypertensive patients 124
Confronto tra candesartan e olmesartan sui parametri correlati alla sensibilità insulinica nei pazienti ipertesi con diabete mellito di tipo 2 124
A clinical trial about a food supplement containing α-lipoic acid on oxidative stress markers in type 2 diabetic patients 124
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes 123
Effetti di pioglitazone e rosiglitazone nei pazienti con diabete di tipo 2 e sindrome metabolica trattati con metformina 123
Confronto tra dieta, orlistat e fluvastatina in soggetti obesi, con ipertensione arteriosa lieve e ipercolesterolemia 123
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome 122
Comparison between orlistat and sibutramine in obese patients with mild hypertension 122
Acarbose compared to placebo on insulin resistance biomarkers in a double-blind, placebo-controlled trial 122
Effects of berberis aristata/silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patients 121
Matrix metalloproteinase 2 may be a marker of microangiopathy compared to metalloproteinase 9 in children and adolescents with type 1 diabetes mellitus: A 5 year follow-up study 121
Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria 120
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 119
Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients 118
A randomized, double-blind clinical trial on the long term efficacy of psyllium husk vs. guar gum on the clinical features of metabolic syndrome 118
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial 117
n-3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia 116
Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus 115
Matrix metalloproteinase-2 activity (MMP-2) in children and adolescents with type 1 diabetes mellitus: Follow-up study 115
A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk 115
Differenti effetti di candesartan e olmesartan sui parametri di attività del tessuto adiposo in pazienti diabetici di tipo 2 ipertesi 114
A curious case of hypoglycaemia 114
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome 113
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients 113
Aliskiren reduces QT dispersion in hypertensive diabetic patients 113
Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients 112
Effetti di un anno di trattamento con vildagliptin associato a pioglitazone o glimepiride in pazienti diabetici scarsamente controllati 112
n-3 PUFAs on metalloproteinases, inflammatory and insulin resistance parameters in dyslipidemic patients after euglycemic clamp and oral fat load. 112
Comparison between glimepiride plus pioglitazone vs. glimepiride plus rosiglitazone on glucose metabolism and on lipid, lipoprotein and apolipoprotein fractions in type 2 diabetic patients 111
Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. 111
Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients 110
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients 110
Comparison between exenatide and glimepiride on metabolic control and on insulin resistance in type 2 diabetic patients with metformin therapy 110
Prevenzione della malattia coronarica: il rischio cardiovascolare globale 110
Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone 109
COVID-19 pandemic impact on people with diabetes: results from a large representative sample of Italian older adults 108
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation 108
Effects of sibutramine plus L-carnitine compared to sibutramine on inflammatory parameters in type 2 diabetic patients 108
Metalloproteasi-2, metalloproteasi-9 ed inibitore tissutale delle metalloproteasi-1 in pazienti ipertesi 108
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 108
A Randomized, Double-Blind, Controlled, Parallel-Group Comparison of Perindopril and Candesartan in Hypertensive Patients with Type 2 Diabetes Mellitus 108
Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study 108
Comparison between fosinopril and eprosartan on lipid profile and Lp(a) in normotensive, type 2 diabetic subjects, with microalbuminuria 107
Effetti di un anno di trattamento con orlistat+L-carnitina paragonato a orlistat o placebo sui parametri di insulino-resistenza nei pazienti diabetici 107
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin in type 2 diabetes patients with metabolic syndrome 107
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 107
Lipoprotein (a) Particles Characterization by Dynamic Light Scattering 107
Doxazosin improves blood pressure and metabolic parameters in impaired glucose tolerance patients in therapy with acarbose 107
Risk management in the treatment of type 2 diabetes with pioglitazone 107
Comparison between orlistat and sibutramine in obese patients with type 2 diabetes mellitus 106
Totale 14.221
Salva come PNG Salva come JPEG
Categoria #
all - tutte 262.087
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 262.087
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.575 0 7 124 17 11 13 30 162 135 45 480 1.551
2022/20238.600 942 532 47 615 1.009 917 7 537 3.523 96 259 116
2023/20242.641 259 500 95 195 353 653 65 256 28 84 61 92
2024/20258.112 76 807 270 280 146 262 689 756 1.743 123 781 2.179
2025/202618.621 1.383 1.355 2.313 2.041 1.850 777 3.783 786 1.563 1.422 909 439
2026/20272.283 963 1.320 0 0 0 0 0 0 0 0 0 0
Totale 61.872